The notices it replaced
Its page names no earlier notice: it is new, or it does not say.
Replaced by PAR-24-274.
Who won it before
38 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,512,675 in first-year total cost, median $149,482.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-Y (O1)]13
- Special Emphasis Panel[ZCA1 SRB-1 (M1)]8
- Special Emphasis Panel[ZCA1 SRB-1 (O1)]6
- Special Emphasis Panel[ZCA1 RPRB-6 (J2)]4
- Special Emphasis Panel[ZCA1 SRB-1 (M2)]4
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY3
- EMORY UNIVERSITY2
- MAYO CLINIC ROCHESTER2
- UNIVERSITY OF KANSAS MEDICAL CENTER2
- UNIVERSITY OF TX MD ANDERSON CAN CTR2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Leading NCI Clinical Trials Network research nationally and at the City of Hope Comprehensive Cancer Center1R50CA285409-01A1 | HERRERA, ALEX F. | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $208,103 | ZCA1 |
| 2024 | Advancing novel cancer preventive and therapeutic strategies across the modern NCI clinical trial networks1R50CA285412-01 | ZELL, JASON | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $196,267 | ZCA1 |
| 2024 | Optimization of strategies to improve NCI-sponsored clinical trial participation throughout the Weill Cornell Medicine - Meyer Cancer Center Sphere1R50CA285498-01A1 | TAGAWA, SCOTT T | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $194,778 | ZCA1 |
| 2024 | Multi-omic liquid biopsy assessment in NCI trials: evaluating ctDNA, extravesicle RNA, and outcomes with immunotherapy in patient with colorectal and anal cancers1R50CA285403-01A1 | MORRIS, VAN K | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $181,640 | ZCA1 |
| 2024 | Advancing novel therapeutics and translational science to close the survivorship gap in pediatric, adolescent and young adult (AYA) lymphoma1R50CA285492-01 | CASTELLINO, SHARON MARIE | EMORY UNIVERSITY, GA | $178,909 | ZCA1 |
| 2024 | Developing, Implementing and Supporting NCI Clinical Trials and the National Cancer Trials Network (NCTN) in Breast Cancer and Developmental Therapeutics- A 5 Year Plan1R50CA278773-01A1 | O'SULLIVAN, CIARA C | MAYO CLINIC ROCHESTER, MN | $177,254 | ZCA1 |
| 2024 | Improving the Processes around Approval, Accrual and Translational Research in Cancer Prevention Trials1R50CA285494-01 | BANSAL, AJAY | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $172,197 | ZCA1 |
| 2024 | Pediatric acute lymphoblastic leukemia: Improving outcomes through incorporation of novel targeted therapies into treatment for relapsed and newly diagnosed disease1R50CA288324-01 | O'BRIEN, MAUREEN MEGAN | UNIVERSITY OF COLORADO DENVER, CO | $172,013 | ZCA1 |
| 2024 | Closing the Adolescent and Young Adult Clinical Trial Enrollment Gap with an AYA (Alert, Young Adult Navigation and Alliance) Clinical Tool1R50CA282101-01A1 | SYMONS, HEATHER JILL | JOHNS HOPKINS UNIVERSITY, MD | $166,984 | ZCA1 |
| 2024 | Increasing Access and Participation to Early Phase Clinical Trials to the Underrepresented Populations1R50CA290098-01 | BARANDA, JOAQUINA C | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $159,574 | ZCA1 |
| 2024 | Enhancing accrual and diversity across gynecologic and solid tumor trials1R50CA285360-01 | DUSKA, LINDA | UNIVERSITY OF VIRGINIA, VA | $135,573 | ZCA1 |
| 2024 | Gynecologic cancer care: Improving clinical trial enrollment through molecular matching with targeted therapies and improving equal access to care and research for all populations1R50CA287196-01 | BACKES, FLOOR J. | OHIO STATE UNIVERSITY, OH | $132,015 | ZCA1 |
| 2024 | Cultivating programmatic efforts to optimize the conduct and implementation of NCI-funded clinical trials1R50CA285499-01A1 | ENG, CATHY | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $130,426 | ZCA1 |
| 2024 | Paradigm Shift in the Management of Patients with Previously Untreated Chronic Lymphocytic Leukemia through NCI-sponsored Clinical Trials1R50CA291823-01 | PARIKH, SAMEER ASHOK | MAYO CLINIC ROCHESTER, MN | $124,230 | ZCA1 |
| 2024 | Research Capacity Building by a Clinician Scientist within the Michigan Cancer Research Consortium- National Community Oncology Research Program1R50CA288382-01 | DIB, ELIE G | SAINT JOSEPH MERCY HEALTH SYSTEM, MI | $113,202 | ZCA1 |
| 2024 | National and Institutional Leadership and Support of NCI-Sponsored Clinical Trial Research as a Surgical Oncologist1R50CA293523-01 | CHAWLA, AKHIL | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $90,538 | ZCA1 |
| 2024 | Steering the next generation of NCI-sponsored clinical trials in gastroesophageal cancers1R50CA291818-01 | KLEMPNER, SAMUEL J | MASSACHUSETTS GENERAL HOSPITAL, MA | $78,951 | ZCA1 |
| 2023 | Dr. Salma Jabbour’s NCI Research Specialist (Clinician Scientist) Award (R50)1R50CA275877-01 | JABBOUR, SALMA | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $196,184 | ZCA1 |
| 2023 | Increasing access to cancer trials in Minnesota (InACT-MN)1R50CA278811-01 | ERICKSON, BRITT KRISTINA | UNIVERSITY OF MINNESOTA, MN | $182,836 | ZCA1 |
| 2023 | Clinical Trials Specialist in Developmental Therapeutics1R50CA278916-01 | HIJIYA, NOBUKO | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $175,944 | ZCA1 |
| 2023 | Pediatric brain tumors: Improving survival through integration of clinical molecular diagnostics and biologically targeted therapies into clinical trials1R50CA275857-01 | LEARY, SARAH ELISABETH SHERR | SEATTLE CHILDREN'S HOSPITAL, WA | $175,338 | ZCA1 |
| 2023 | NCI Clinical Trial Research Strategy, Harnessing of Equity, and Implementation1R50CA282102-01 | MAYADEV, JYOTI | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $173,920 | ZCA1 |
| 2023 | Interventional oncology clinical research specialist1R50CA276008-01 | SOULEN, MICHAEL C | UNIVERSITY OF PENNSYLVANIA, PA | $173,119 | ZCA1 |
| 2023 | Dr. Kim R50 Research Specialist Clinician 20221R50CA276015-01 | KIM, MICHELLE MIRAN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $171,684 | ZCA1 |
| 2023 | Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint1R50CA278859-01 | WAGNER-JOHNSTON, NINA DELANEY | JOHNS HOPKINS UNIVERSITY, MD | $160,532 | ZCA1 |
| 2023 | Increasing Participation in NCI-Funded Clinical Trials at Winship Cancer Institute1R50CA276010-01A1 | COHEN, JONATHON B. | EMORY UNIVERSITY, GA | $156,603 | ZCA1 |
| 2023 | Development, review, and conduct of Children's Oncology Group (COG) Clinical Trials1R50CA275931-01 | DOME, JEFFREY S | CHILDREN'S RESEARCH INSTITUTE, DC | $142,360 | ZCA1 |
| 2023 | NCI Research Specialist (Clinician Scientist) Award1R50CA275928-01 | FOSTER, JENNIFER HAUNANI | BAYLOR COLLEGE OF MEDICINE, TX | $137,163 | ZCA1 |
| 2023 | Clinician Scientist in Leukemia1R50CA275927-01 | UY, GEOFFREY L | WASHINGTON UNIVERSITY, MO | $132,781 | ZCA1 |
| 2023 | Overcoming Challenges Posed by Biomarker-Selective Clinical Trials: The Role of a Research Specialist1R50CA275932-01 | GAILLARD, STEPHANIE | JOHNS HOPKINS UNIVERSITY, MD | $121,863 | ZCA1 |
| 2023 | NCI-sponsored Clinical Trial Research Specialist1R50CA281930-01 | GEORGE, THOMAS J. | UNIVERSITY OF FLORIDA, FL | $115,272 | ZCA1 |
| 2023 | NCI Research Specialist/Clinician Scientist Award for Urologic Oncology Research1R50CA278913-01 | SHUCH, BRIAN | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $114,720 | ZCA1 |
| 2023 | Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.1R50CA282100-01 | MEHNERT, JANICE M. | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $110,706 | ZCA1 |
| 2023 | Clinician Scientist Supporting NCI-funded Clinical Trials at the Medical College of Wisconsin Cancer Center1R50CA275856-01 | HAMADANI, MEHDI HUSSAIN | MEDICAL COLLEGE OF WISCONSIN, WI | $110,604 | ZCA1 |
| 2023 | NCI Research Specialist (Clinician Scientist) Award1R50CA276021-01 | GOODMAN, KARYN A. | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $91,123 | ZCA1 |
| 2023 | NCI R50 Clinician Scientist Award1R50CA276013-01 | JONAS, BRIAN A. | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $86,737 | ZCA1 |
| 2023 | A radiation oncology clinician scientist devoted to building an inclusive clinical research program in an integrated academic satellite network in service to the National Cancer Institute1R50CA275822-01 | CHUN, STEPHEN G | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $86,702 | ZCA1 |
| 2023 | Curing Through Collaboration: Utilizing Cooperative Groups in the Fight Against Chronic Lymphocytic Leukemia and B-cell Lymphomas1R50CA275929-01 | STEPHENS, DEBORAH | UNIVERSITY OF UTAH, UT | $83,830 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.